Clinical trials
Completed Phase 2 Lung Diseases, Interstitial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Michael Roth | 2 |
| Anne Holland | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Bastiaan Driehuys | 1 |
| Biogen | 1 |
| Bristol-Myers Squibb | 1 |
| Genentech, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| InSilico Medicine Hong Kong Limited | 1 |
| Insmed Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases, Interstitial | 20 |
| Idiopathic Pulmonary Fibrosis | 6 |
| Pulmonary Fibrosis | 6 |
| Hypertension, Pulmonary | 5 |
| Scleroderma, Systemic | 4 |
| Idiopathic Interstitial Pneumonias | 3 |
| Pulmonary Arterial Hypertension | 3 |
| Scleroderma, Diffuse | 3 |
| Lung Diseases | 2 |
| Respiratory Tract Diseases | 2 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.